2013
DOI: 10.1051/proc/201341004
|View full text |Cite
|
Sign up to set email alerts
|

Mathematical model of cancer growth controled by metronomic chemotherapies

Abstract: Abstract. We propose in this article to compare the efficiency of two chemotherapeutic schedules: the traditional and the metronomic. For this, we develop a new mathematical model describing the growth dynamics of tumor and endothelial cells as well as the impact of molecules as oxygen or vascular endothelial growth factor on this dynamics. The model construction: biological assumptions, description of the equations and their discretization, constitutes the core of the article. Numerical experiments illustrate… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
17
0
1

Year Published

2014
2014
2018
2018

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(18 citation statements)
references
References 61 publications
0
17
0
1
Order By: Relevance
“…The biological rationale for this therapeutic strategy [64] is usually (and has initially been) presented as efficiently limiting tumor neoangiogenesis, which thrives during treatment interruptions, allowing tumors to regrow even stronger, which leads treat-ments to failures. Note that metronomic therapies are also supported by another recent model [94] based on a previous multiscale physiological model of tumor growth with angiogenesis [55]. It is also noteworthy that on different bases, without involving neoangiogenesis, but in a chronotherapeutic setting, other theoretical studies [59,74] have also led to the conclusion that avoiding treatment interruptions during long time intervals, but on the contrary administering a chemotherapy on a 24 hour-periodic basis with a short actual drug infusion time during this 24 hour-period, is an optimal (in fact only suboptimal, in as much as in its principle it searches for necessary, but not sufficient, conditions of optimality) strategy.…”
Section: Metronomic Therapiesmentioning
confidence: 82%
“…The biological rationale for this therapeutic strategy [64] is usually (and has initially been) presented as efficiently limiting tumor neoangiogenesis, which thrives during treatment interruptions, allowing tumors to regrow even stronger, which leads treat-ments to failures. Note that metronomic therapies are also supported by another recent model [94] based on a previous multiscale physiological model of tumor growth with angiogenesis [55]. It is also noteworthy that on different bases, without involving neoangiogenesis, but in a chronotherapeutic setting, other theoretical studies [59,74] have also led to the conclusion that avoiding treatment interruptions during long time intervals, but on the contrary administering a chemotherapy on a 24 hour-periodic basis with a short actual drug infusion time during this 24 hour-period, is an optimal (in fact only suboptimal, in as much as in its principle it searches for necessary, but not sufficient, conditions of optimality) strategy.…”
Section: Metronomic Therapiesmentioning
confidence: 82%
“…schedules consisting of many, equally spaced and generally low doses of chemotherapeutic drugs without extended rest periods (see e.g. [80,81]).…”
Section: Discussionmentioning
confidence: 99%
“…Atualmente a modelagem matemática em cânceré uma linha de pesquisa em pleno desenvolvimento que permite descrever os mecanismos de surgimento e tratamento da doença [1]. Se o cálculo de ordem não inteira munido com equações diferenciais que descrevam fenômenos físicosúteis já assume grande importância na obtenção de novos resultados, quando ligado a equações referente a crescimento tumoral essa relevânciaé ainda maior.…”
unclassified